Noncoding RNA and Cardiomyocyte Proliferation

Shuang Qu1, Chunyu Zeng1, Wei Eric Wang1

  • 1Department of Cardiology, Chongqing Institute of Cardiology & Chongqing Cardiovascular Clinical Research Center, Daping Hospital, Third Military Medical University, Chongqing 400042, China.

Stem Cells International
|December 12, 2017
PubMed

Insights

Stimulating cardiomyocyte proliferation is key for cardiac regeneration. This review highlights how noncoding RNAs, especially microRNAs, regulate cardiomyocyte proliferation and offers potential therapeutic targets for heart repair.

Area of Science:

  • Cardiovascular Biology
  • Molecular Biology
  • Regenerative Medicine

Background:

  • Postnatal mammalian cardiomyocytes (CMs) exhibit limited turnover, hindering cardiac repair.
  • Newly formed CMs originate from pre-existing ones, emphasizing the need to stimulate CM proliferation for regeneration.
  • Noncoding RNAs show differential expression in CMs with varying proliferative capacities.

Purpose of the Study:

  • To review the regulatory roles of noncoding RNAs in cardiomyocyte proliferation.
  • To explore the potential of manipulating noncoding RNAs for cardiac regeneration strategies.

Main Methods:

  • Literature review of studies investigating noncoding RNAs and cardiomyocyte proliferation.
  • Analysis of research on microRNA manipulation impacting CM proliferation.
  • Synthesis of findings on the mechanisms underlying noncoding RNA-mediated CM regulation.

Main Results:

  • Noncoding RNAs are differentially expressed in CMs based on proliferation potential.
  • MicroRNA manipulation can either promote or inhibit cardiomyocyte proliferation.
  • Noncoding RNAs are integral to the molecular mechanisms governing CM proliferation.

Conclusions:

  • Noncoding RNAs are critical regulators of cardiomyocyte proliferation.
  • Targeting noncoding RNAs presents a promising avenue for enhancing cardiac regeneration.
  • Understanding these regulatory roles is essential for developing novel therapeutic strategies for heart disease.

Related Concept Videos

Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
6.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
9.9K
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
73.2K
Ribosomal RNA Synthesis02:53

Ribosomal RNA Synthesis

Ribosome synthesis is a highly complex and coordinated process involving more than 200 assembly factors. The synthesis and processing of ribosomal components occurs not only in the nucleolus but also in the nucleoplasm and the cytoplasm of eukaryotic cells.
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
14.9K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.8K